BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15025748)

  • 1. Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females.
    Wenk M; Todesco L; Krähenbühl S
    Br J Clin Pharmacol; 2004 Apr; 57(4):495-9. PubMed ID: 15025748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P; Haefeli WE; Ledermann HR; Wenk M
    Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of peppermint tea consumption on the activities of CYP1A2, CYP2A6, Xanthine Oxidase, N-acetyltranferase-2 and UDP-glucuronosyltransferases-1A1/1A6 in healthy volunteers.
    Begas E; Tsioutsiouliti A; Kouvaras E; Haroutounian SA; Kasiotis KM; Kouretas D; Asprodini E
    Food Chem Toxicol; 2017 Feb; 100():80-89. PubMed ID: 28011360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in drug metabolizing enzyme activity in HIV-infected patients.
    Jones AE; Brown KC; Werner RE; Gotzkowsky K; Gaedigk A; Blake M; Hein DW; van der Horst C; Kashuba AD
    Eur J Clin Pharmacol; 2010 May; 66(5):475-85. PubMed ID: 20084375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug.
    Vrtic F; Haefeli WE; Drewe J; Krähenbühl S; Wenk M
    Br J Clin Pharmacol; 2003 Feb; 55(2):191-8. PubMed ID: 12580991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS
    Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.
    Rasmussen BB; Brøsen K
    Ther Drug Monit; 1996 Jun; 18(3):254-62. PubMed ID: 8738764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6.
    Nakao M; Muramoto Y; Hisadome M; Yamano N; Shoji M; Fukushima Y; Saruwatari J; Nakagawa K
    Eur J Clin Pharmacol; 2007 Apr; 63(4):345-53. PubMed ID: 17297618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities.
    Hakooz NM
    Curr Drug Metab; 2009 May; 10(4):329-38. PubMed ID: 19519341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
    Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans.
    Tsutsumi K; Kotegawa T; Matsuki S; Tanaka Y; Ishii Y; Kodama Y; Kuranari M; Miyakawa I; Nakano S
    Clin Pharmacol Ther; 2001 Aug; 70(2):121-5. PubMed ID: 11503005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.
    Kennedy MJ; Scripture CD; Kashuba AD; Scott CS; Gaedigk A; Kearns GL
    Clin Pharmacol Ther; 2004 Mar; 75(3):163-71. PubMed ID: 15001967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
    Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
    Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.
    Nyéki A; Biollaz J; Kesselring UW; Décosterd LA
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):73-84. PubMed ID: 11393735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers.
    Saruwatari J; Takaishi C; Yoshida K; Takashima A; Fujimura Y; Umemoto Y; Abe T; Kitamado M; Shimomasuda M; Muramoto Y; Nakagawa K
    J Pharm Pharmacol; 2012 May; 64(5):670-6. PubMed ID: 22471362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping.
    Kashuba AD; Bertino JS; Kearns GL; Leeder JS; James AW; Gotschall R; Nafziger AN
    Clin Pharmacol Ther; 1998 May; 63(5):540-51. PubMed ID: 9630827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping.
    Kashuba AD; Nafziger AN; Kearns GL; Leeder JS; Gotschall R; Rocci ML; Kulawy RW; Beck DJ; Bertino JS
    Clin Pharmacol Ther; 1998 Sep; 64(3):257-68. PubMed ID: 9757149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary effects of Sideritis scardica "mountain tea" on human in vivo activities of xenobiotic metabolizing enzymes in healthy subjects.
    Begas E; Kilindris T; Kouvaras E; Tsioutsioumi A; Kouretas D; Asprodini EK
    Food Chem Toxicol; 2018 Dec; 122():38-48. PubMed ID: 30266316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.